Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of MenABCWY Vaccine
NCT03587207Phase 2Completed
- Sponsor
- GSK
- Start
- Jul 2018
- Primary completion
- Dec 2018
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of MENABCWY-1GEN in meningococcal meningitis, sponsored by GSK. Started Jul 2018; status: completed.
02
Drugs
MENABCWY-1GEN
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on NCT03587207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03587207.